Treatment of symptomatic middle cerebral artery stenosis with balloon-mounted stents: Long-term follow-up at a single center

Neurosurgery

Volumn 64, Issue 1, 2009, Pages 79-84

  Miao, Zhongrong R ^a   Feng, Lei ^b   Li, Shengmao ^a   Zhu, Fengshui ^a   Ji, Xunming ^a   Jiao, Liqun ^a   Ling, Feng ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Angioplasty; Follow up; Middle cerebral artery; Stent

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; TICLOPIDINE;

ACUTE DISEASE; ADULT; AGED; ANGIOGRAPHY; ARTICLE; BALLOON EXPANDABLE CORONARY STENT; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CORONARY STENT; DIABETES MELLITUS; DOPPLER ECHOGRAPHY; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; PERIOPERATIVE COMPLICATION; PRIORITY JOURNAL; RESTENOSIS; REVASCULARIZATION; STROKE; TRANSIENT ISCHEMIC ATTACK; BRAIN ANGIOGRAPHY; CEREBRAL ARTERY DISEASE; CEREBRAL REVASCULARIZATION; INSTRUMENTATION; MIDDLE AGED; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RETROSPECTIVE STUDY; STENOSIS, OCCLUSION AND OBSTRUCTION; STENT;

ADULT; AGED; ANGIOPLASTY, BALLOON; CEREBRAL ANGIOGRAPHY; CEREBRAL REVASCULARIZATION; CONSTRICTION, PATHOLOGIC; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STENTS; STROKE;

EID: 62449145529     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000335648.31874.37     Document Type: Article

References (36)

1. Abou-Chebl A, Bashir Q, Yadav JS: Drug-eluting stents for the treatment of intracranial atherosclerosis: Initial experience and midterm angiographic follow-up. Stroke 36:e165-e168, 2005.
2. Arenillas JF, Molina CA, Montaner J, Abilleira S, Gonzalez-Sanchez MA, Alvarez-Sabín J: Progression and clinical recurrence of symptomatic middle cerebral artery stenosis: A long-term follow-up transcranial Doppler ultrasound study. Stroke 32:2898-2904, 2001.
3. Bogousslavsky J, Barnett HJ, Fox AJ, Hachinski VC, Taylor W: Atherosclerotic disease of the middle cerebral artery. Stroke 17:1112-1120, 1986.
4. Bose A, Hartmann M, Henkes H, Liu HM, Teng MM, Szikora I, Berlis A, Reul J, Yu SC, Forsting M, Lui M, Lim W, Sit SP: A novel, self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses: The Wingspan study. Stroke 38:1531-1537, 2007.
5. Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, Levine SR, Chaturvedi S, Kasner SE, Benesch CG, Sila CA, Jovin TG, Romano JG; Warfarin-Aspirin Symptomatic Intracranial Disease Trial Investigators: Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 352:1305-1316, 2005.
6. Connors JJ 3rd, Wojak JC: Percutaneous transluminal angioplasty for intracranial atherosclerotic lesions: Evolution of technique and short-term results. J Neurosurg 91:415-423, 1991.
7. EC/IC Bypass Study Group: Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. Results of an international randomized trial. The EC/IC Bypass Study Group. N Engl J Med 313:1191-1200, 1985.
8. Fiorella D, Chow MM, Anderson M, Woo H, Rasmussen PA, Masaryk TJ: A 7-year experience with balloon-mounted coronary stents for the treatment of symptomatic vertebrobasilar intracranial atheromatous disease. Neurosurgery 61:236-243, 2007.
9. Fiorella D, Levy EI, Turk AS, Albuquerque FC, Niemann DB, Aagaard-Kienitz B, Hanel RA, Woo H, Rasmussen PA, Hopkins LN, Masaryk TJ, McDougall CG: US multicenter experience with the Wingspan stent system for the treatment of intracranial atheromatous disease: Periprocedural results. Stroke 38:881-887, 2007.
10. Freitas JM, Zenteno M, Aburto-Murrieta Y, Koppe G, Abath C, Nunes JA, Raupp E, Hidalgo R, Pieruccetti MA, Lee A: Intracranial arterial stenting for symptomatic stenoses: A Latin American experience. Surg Neurol 68:378-386, 2007.
11. Gomez CR, Misra VK, Campbell MS, Soto RD: Elective stenting of symptomatic middle cerebral artery stenosis. AJNR Am J Neuroradiol 21:971-973, 2000.
12. Gupta R, Al-Ali F, Thomas AJ, Horowitz MB, Barrow T, Vora NA, Uchino K, Hammer MD, Wechsler LR, Jovin TG: Safety, feasibility, and short-term follow-up of drug-eluting stent placement in the intracranial and extracranial circulation. Stroke 37:2562-2566, 2006.
13. Henkes H, Miloslavski E, Lowens S, Reinartz J, Liebig T, Kuhne D: Treatment of intracranial atherosclerotic stenoses with balloon dilatation and self-expanding stent deployment (WingSpan). Neuroradiology 47:222-228, 2005.
14. Jiang WJ, Srivastava T, Gao F, Du B, Dong KH, Xu XT: Perforator stroke after elective stenting of symptomatic intracranial stenosis. Neurology 66:1868-1872, 2006.
15. Jiang WJ, Wang YJ, Du B, Wang SX, Wang GH, Jin M, Dai JP: Stenting of symptomatic M1 stenosis of middle cerebral artery: An initial experience of 40 patients. Stroke 35:1375-1380, 2004.
16. Kasner SE, Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, Levine SR, Chaturvedi S, Benesch CG, Sila CA, Jovin TG, Romano JG, Cloft HJ; Warfarin Aspirin Symptomatic Intracranial Disease Trial Investigators: Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation 113:555-563, 2006.
17. Kim JK, Ahn JY, Lee BH, Chung YS, Chung SS, Kim OJ, Kim WC, Joo JY: Elective stenting for symptomatic middle cerebral artery stenosis presenting as transient ischaemic deficits or stroke attacks: Short term arteriographical and clinical outcome. J Neurol Neurosurg Psychiatry 75:847-851, 2004.
18. Lee TH, Kim DH, Lee BH, Kim HJ, Choi CH, Park KP, Jung DS, Kim S, Moon TY: Preliminary results of endovascular stent-assisted angioplasty for symptomatic middle cerebral artery stenosis. AJNR Am J Neuroradiol 26:166-174, 2005.
19. Levy EI, Turk AS, Albuquerque FC, Niemann DB, Aagaard-Kienitz B, Pride L, Purdy P, Welch B, Woo H, Rasmussen PA, Hopkins LN, Masaryk TJ, McDougall CG, Fiorella DJ: Wingspan in-stent restenosis and thrombosis: Incidence, clinical presentation, and management. Neurosurgery 61:644-651, 2007.
20. Marks MP, Marcellus ML, Do HM, Schraedley-Desmond PK, Steinberg GK, Tong DC, Albers GW: Intracranial angioplasty without stenting for symptomatic atherosclerotic stenosis: Long-term follow-up. AJNR Am J Neuroradiol 26:525-530, 2005.
21. Marks MP, Marcellus M, Norbash AM, Steinberg GK, Tong D, Albers GW: Outcome of angioplasty for atherosclerotic intracranial stenosis. Stroke 30:1065-1069, 1999.
22. Marks MP, Wojak JC, Al-Ali F, Jayaraman M, Marcellus ML, Connors JJ, Do HM: Angioplasty for symptomatic intracranial stenosis: Clinical outcome. Stroke 37:1016-1020, 2006.
23. Mazighi M, Tanasescu R, Ducrocq X, Vicaut E, Bracard S, Houdart E, Woimant F: Prospective study of symptomatic atherothrombotic intracranial stenoses: The GESICA study. Neurology 66:1187-1191, 2006.
24. Mori T, Fukuoka M, Kazita K, Mori K: Follow-up study after intracranial percutaneous transluminal cerebral balloon angioplasty. AJNR Am J Neuroradiol 19:1525-1533, 1998.
25. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, Molnàr F, Falotico R; RAVEL Study Group: Randomized study with the Sirolimus-coated BX velocity balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions: A randomized comparison of a Sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346:1773-1780, 2002.
26. Navarro JC, Lao AY, Sharma VK, Tsivgoulis G, Alexandrov AV: The accuracy of transcranial Doppler in the diagnosis of middle cerebral artery stenosis. Cerebrovasc Dis 23:325-330, 2007.
27. Qureshi AI, Ziai WC, Yahia AM, Mohammad Y, Sen S, Agarwal P, Zaidat OO, Suarez JI, Wityk RJ: Stroke-free survival and its determinants in patients with symptomatic vertebrobasilar stenosis: A multicenter study. Neurosurgery 52:1033-1040, 2003.
28. Samuels OB, Joseph GJ, Lynn MJ, Smith HA, Chimowitz MI: A standardized method for measuring intracranial arterial stenosis. AJNR Am J Neuroradiol 21:643-646, 2000.
29. SSYLVIA Study Investigators: Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): Study results. Stroke 35:1388-1392, 2004.
30. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Popma JJ, Russell ME; Taxus-IV Investigators: A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350:221-231, 2004.
31. Takis C, Kwan ES, Pessin MS, Jacobs DH, Caplan LR: Intracranial angioplasty: Experience and complications. AJNR Am J Neuroradiol 18:1661-1668, 1997.
32. Thijs VN, Albers GW: Symptomatic intracranial atherosclerosis: Outcome of patients who fail antithrombotic therapy. Neurology 55:490-497, 2000.
33. Turk AS, Levy EI, Albuquerque FC, Pride GL Jr, Woo H, Welch BG, Niemann DB, Purdy PD, Aagaard-Kienitz B, Rasmussen PA, Hopkins LN, Masaryk TJ, McDougall CG, Fiorella D: Influence of patient age and stenosis location on Wingspan in-stent restenosis. AJNR Am J Neuroradiol 29:23-27, 2007.
34. Wityk RJ, Lehman D, Klag M, Coresh J, Ahn H, Litt B: Race and sex differences in the distribution of cerebral atherosclerosis. Stroke 27:1974-1980, 1996.
35. Wong KS, Li H, Lam WW, Chan YL, Kay R: Progression of middle cerebral artery occlusive disease and its relationship with further vascular events after stroke. Stroke 33:532-536, 2002.
36. Yokote H, Terada T, Ryujin K, Konoshita Y, Tsuura M, Nakai E, Kamei I, Moriwaki H, Hayashi S, Itakura T: Percutaneous transluminal angioplasty for intracranial arteriosclerotic lesions. Neuroradiology 40:590-596, 1998.